What are Type I vs. Type II Errors in Hypothesis Testing? Difference & Examples

Getting your Trinity Audio player ready...

Contents

• Glossary of Key Terms
• Key Takeaways
• Introduction: Hypothesis Testing and the Risk of Error
• Null and Alternative Hypotheses: The Foundation
• What Is a Type I Error?
• What Is a Type II Error?
• The Four Possible Outcomes of a Hypothesis Test
• Type I vs. Type II Errors: A Direct Comparison
• How Do Alpha and Beta Trade Off Against Each Other?
• Alpha, Beta, and Statistical Power in Detail
• Effect Size: Why Magnitude Matters
• The p-Value: What It Does and Does Not Mean
• Which Error Is Worse: Type I or Type II?
• Strategies for Minimizing Type I and Type II Errors
• Multiple Testing: When Running Many Tests Inflates Type I Error
• Real-World Examples Across Disciplines
• Errors Due to Bias vs. Random Error
• How Does Hypothesis Quality Affect Error Rates?
• Practical Guidance for Researchers and Analysts
• Frequently Asked Questions

Glossary of Key Terms

The following definitions provide a reference for terms used throughout this guide.

Term	Definition
Alpha (α)	The significance level; the maximum probability of committing a Type I error, set before the study begins. Common values: 0.01, 0.05, 0.10.
Alternative Hypothesis (H1 / Ha)	The research prediction that a real effect, difference, or relationship exists in the population.
Beta (β)	The probability of committing a Type II error; the chance of missing a real effect. Typical target: 0.20.
Effect Size	The magnitude of the association or difference being tested. Larger effects are easier to detect.
False Discovery Rate (FDR)	In multiple testing: the expected proportion of significant results that are actually false positives.
False Negative	Synonym for Type II error. Concluding no effect exists when one actually does.
False Positive	Synonym for Type I error. Concluding an effect exists when it actually does not.
Family-Wise Error Rate (FWER)	In multiple testing: the probability of making at least one Type I error across all tests performed.
Null Hypothesis (H0)	The default assumption that no effect, difference, or relationship exists in the population.
p-value	The probability of obtaining the observed results (or more extreme ones) assuming the null hypothesis is true.
Power (1 − β)	The probability that a test correctly detects a true effect. A power of 0.80 (80%) is a widely accepted minimum.
Sample Size (n)	The number of observations in a study. Larger samples reduce both Type I and Type II error risks.
Statistical Significance	Achieved when the p-value falls below the predetermined alpha threshold, indicating results unlikely under H0.
Type I Error	Rejecting a null hypothesis that is actually true. Equivalent to a false positive. Probability equals alpha.
Type II Error	Failing to reject a null hypothesis that is actually false. Equivalent to a false negative. Probability equals beta.

Key Takeaways

• A Type I error (false positive) occurs when a true null hypothesis is rejected; its probability is controlled by the significance level alpha.
• A Type II error (false negative) occurs when a false null hypothesis is not rejected; its probability is beta, and (1 − beta) is the statistical power.
• The two error types are inversely linked: reducing alpha (lowering Type I risk) automatically raises beta (raising Type II risk), and vice versa.
• Statistical power is the probability of correctly detecting a real effect; it is increased by enlarging sample size, raising alpha, or targeting larger effect sizes.
• Effect size is the magnitude of the true difference or association. Smaller effects are harder to detect and raise the Type II error risk.
• Conventional thresholds are alpha = 0.05 and beta = 0.20 (power = 0.80), but the appropriate values depend on the real-world cost of each error type.
• Multiple simultaneous tests inflate the Type I error rate; corrections such as Bonferroni or Benjamini-Hochberg are used to control this inflation.
• Neither error can be eliminated entirely when inferences are based on sample data; the goal is to balance and minimize both.
• In clinical and safety contexts, Type II errors (missed effects) can be life-threatening; in regulatory contexts, Type I errors (false approvals) carry the greater risk.
• The p-value does not prove the null hypothesis is true or false; it only indicates how consistent the data are with the null hypothesis.

Introduction: Hypothesis Testing and the Risk of Error

Every scientific conclusion drawn from sample data carries uncertainty. Hypothesis testing is the formal framework for managing that uncertainty: it allows researchers to decide whether observed data provide enough evidence to reject a default assumption (the null hypothesis) in favor of a research prediction (the alternative hypothesis). Because the true state of the world is unknown, this process is inherently probabilistic, and two distinct types of incorrect conclusions can result.

The analogy of a judge deciding a criminal case captures the logic well. A judge begins by presuming innocence (the null hypothesis). Based on the evidence presented, the judge must decide whether to convict or acquit. A judge can err in two ways: convicting an innocent person or acquitting a guilty one. Statistical hypothesis testing presents the same two error possibilities, each with its own name, probability, and set of consequences.

Null and Alternative Hypotheses: The Foundation

Before errors can be understood, the structure of the hypotheses being tested must be clear. In formal terms:

• The null hypothesis (H0) states that no association, effect, or difference exists between variables in the population. It serves as the default starting position and the target of the statistical test.
• The alternative hypothesis (H1 or Ha) states that a real association or difference does exist. It is accepted by exclusion: if the null hypothesis is rejected, the alternative is supported.

A well-formed hypothesis is simple (one predictor, one outcome), specific (no ambiguity about measurement or subjects), and stated before data collection to prevent post hoc manipulation.

One-Tailed vs. Two-Tailed Hypotheses

The direction of the alternative hypothesis determines whether a one-tailed or two-tailed test is used.

Feature	One-Tailed Test	Two-Tailed Test
Direction tested	One specified direction (e.g., greater than)	Either direction (greater or less)
When appropriate	Only one direction is scientifically meaningful	Either direction is possible and relevant
Sample size needed	Smaller (for equivalent power)	Larger
Risk of misuse	Higher (data dredging temptation)	Lower

What Is a Type I Error?

A Type I error is a false positive: the investigator rejects the null hypothesis when it is actually true in the population. The result looks statistically significant, but the apparent effect is the product of random sampling variation, not a genuine difference or relationship.

Probability and the Significance Level

The probability of committing a Type I error is denoted alpha (α), which is also called the significance level or the level of statistical significance. Alpha is set by the researcher before data collection begins. Common choices are:

• α = 0.05: a 5% chance of incorrectly rejecting the null hypothesis. The most widely used threshold.
• α = 0.01: a 1% chance. Used when the cost of a false positive is high, such as in pharmaceutical approval decisions.
• α = 0.10: a 10% chance. Used in exploratory research where identifying potential leads matters more than avoiding false positives.

When the p-value returned by a statistical test falls below alpha, the result is declared statistically significant and the null hypothesis is rejected. However, this does not prove the null is false; it only indicates that the observed data would be unlikely to arise by chance if the null were true.

The Critical Region

The significance level defines the critical region of the test’s sampling distribution: the set of outcomes extreme enough to trigger rejection of the null hypothesis. If the test statistic lands in this region, the result is declared significant. Because this region is defined in advance and has a fixed probability mass of alpha, roughly alpha-proportion of correct null hypotheses will be rejected by chance alone across repeated studies.

Context	Null Hypothesis (H0)	Type I Error Consequence
Medical diagnosis	Patient does not have the disease	Healthy patient is told they have the disease; unnecessary treatment, anxiety
Drug trial	New drug is no more effective than placebo	Ineffective drug is approved; patients exposed to side effects with no benefit
Criminal trial	Defendant is innocent	Innocent person is convicted and punished
Quality control	Product meets specifications	Conforming product is scrapped; wasted cost
A/B testing	New website version performs the same	Business deploys a change that provides no real benefit

What Is a Type II Error?

A Type II error is a false negative: the investigator fails to reject the null hypothesis when it is actually false. The test does not detect a real effect, difference, or relationship that genuinely exists in the population.

Probability and the Concept of Power

The probability of a Type II error is denoted beta (β). Its complement, (1 − β), is statistical power: the probability that the test correctly detects a real effect.

• A power of 0.80 (beta = 0.20) means the test has an 80% chance of detecting the effect if it exists. This is the conventional minimum.
• A power of 0.90 (beta = 0.10) offers better detection and is used in studies where missing an effect has serious consequences.

A Type II error does not prove the null hypothesis is true. It only means the study lacked sufficient evidence, often due to too small a sample size or too weak an effect relative to the noise in the data.

Type II Error Examples Across Domains

Context	Null Hypothesis (H0)	Type II Error Consequence
Medical diagnosis	Patient does not have the disease	Sick patient is told they are healthy; disease progresses untreated
Drug trial	New drug is no more effective than placebo	Effective drug is rejected; patients miss a beneficial treatment
Criminal trial	Defendant is innocent	Guilty person is acquitted and goes unpunished
Quality control	Product meets specifications	Defective product passes inspection and reaches consumers
A/B testing	New website version performs the same	Business abandons an improvement that would have increased revenue

The Four Possible Outcomes of a Hypothesis Test

Any hypothesis test, when completed, falls into one of four cells defined by the true state of the population and the decision made from the sample.

	H0 Is True (No Real Effect)	H0 Is False (Real Effect Exists)
Reject H0	Type I Error (false positive) Probability = α	Correct Decision Probability = 1 − β (Power)
Fail to Reject H0	Correct Decision Probability = 1 − α	Type II Error (false negative) Probability = β

Only two of the four cells are accessible to the researcher: the two decisions (reject or fail to reject). The true state of the population is always unknown. This is why error control, not error elimination, is the goal of study design.

Type I vs. Type II Errors: A Direct Comparison

Feature	Type I Error	Type II Error
Also called	False positive, alpha error	False negative, beta error
What happens	Reject H0 when H0 is true	Fail to reject H0 when H0 is false
Symbol	α (alpha)	β (beta)
Controlled by	Setting significance level (alpha)	Increasing power via sample size
Typical target	α ≤ 0.05	β ≤ 0.20 (power ≥ 0.80)
Direction of error	Overclaims an effect	Underclaims; misses an effect
Relation to p-value	p < α triggers rejection (may be erroneous)	p > α fails to trigger rejection (may miss truth)
Impact of larger sample	Slightly reduced (more precise estimates)	Substantially reduced (more power)

How Do Alpha and Beta Trade Off Against Each Other?

Alpha and beta are not independent: tightening control over one automatically loosens control over the other, when sample size and effect size are held constant. This is the fundamental trade-off in hypothesis test design.

• Lowering alpha (stricter false-positive control) shifts the rejection threshold further into the tail of the null distribution. This raises the bar for significance and therefore increases the chance of missing a real effect, meaning beta rises.
• Raising alpha (looser false-positive control) moves the rejection threshold closer to the center of the distribution, making it easier to detect effects but also easier to produce false positives.
• Increasing sample size is the only way to reduce both alpha and beta simultaneously, because larger samples produce narrower sampling distributions and therefore more precise estimates.
• Increasing effect size: if the true effect in the population is larger, the alternative hypothesis distribution shifts further from the null, reducing the overlap between the two distributions and thereby reducing beta without affecting alpha.

Visualizing the Overlap

Conceptually, two bell-shaped distributions sit on the same axis: one representing the null hypothesis and one representing the alternative. The Type I error rate (alpha) is the tail area of the null distribution beyond the critical value. The Type II error rate (beta) is the area of the alternative distribution that falls short of the critical value. When the critical value moves left (higher alpha), beta decreases; when it moves right (lower alpha), beta increases.

Alpha, Beta, and Statistical Power in Detail

Setting Alpha

Alpha should be chosen before data collection based on the research context, specifically the relative severity of a false positive versus a false negative for the question at hand. Researchers typically choose from the following range:

Alpha Value	Type I Error Risk	Typical Use Case
0.10	10%	Exploratory or pilot research; generating hypotheses
0.05	5%	Standard threshold for most applied and social science research
0.01	1%	Regulatory or clinical decisions; high-stakes approvals
0.001	0.1%	Genetic research; high-dimensional testing with many comparisons

Setting Beta and Computing Required Power

Power analysis is conducted prior to data collection to determine the minimum sample size needed to detect a specified effect with a chosen power level. The inputs are:

• The significance level (alpha).
• The desired power (commonly 0.80 or 0.90).
• The expected effect size (estimated from prior literature or pilot data, or set to the smallest clinically meaningful magnitude).

Once these three values are fixed, sample size can be computed from standard power analysis formulas or software. If available participants are limited, the researcher may instead compute the minimum detectable effect size and assess whether it is scientifically meaningful.

What Factors Determine Statistical Power?

Factor	Effect on Power	How to Leverage It
Sample size	Power increases with n	Recruit more participants; pool data across sites
Effect size	Power increases with larger effects	Target the minimum meaningful effect; use sensitive instruments
Alpha level	Power increases with higher alpha	Accept higher false-positive risk in exploratory work
Measurement error	Power decreases with noise	Use validated, reliable measurement instruments
Study design	Within-subjects designs often increase power	Use paired or repeated-measures designs where appropriate

Effect Size: Why Magnitude Matters

The effect size quantifies the practical magnitude of the association or difference being investigated. It is distinct from statistical significance: a result can be statistically significant with a trivially small effect (in large samples), or practically meaningful but non-significant (in small samples).

Researchers must specify an expected or minimum clinically meaningful effect size when designing a study, because it directly determines the required sample size. Common standardized measures of effect size include:

Measure	Applied To	Small / Medium / Large Benchmark
Cohen’s d	Difference between two means	0.2 / 0.5 / 0.8
Pearson r	Correlation between two variables	0.1 / 0.3 / 0.5
Odds Ratio (OR)	Binary outcomes in clinical trials	1.5 / 2.5 / 4.0 (approximately)
Eta-squared (η²)	Variance explained in ANOVA	0.01 / 0.06 / 0.14

A smaller effect size requires a larger sample to achieve the same power. When the investigator has no prior data to estimate effect size, the most defensible strategy is to define the smallest effect that would be considered clinically or practically meaningful and design the study to detect that threshold reliably.

The p-Value: What It Does and Does Not Mean

The p-value is the probability of obtaining the observed results, or results more extreme, if the null hypothesis were true. It is not the probability that the null hypothesis is correct. It is not the probability that the result is due to chance. It is not a measure of effect size or practical importance.

How the p-Value Relates to Error Types

Scenario	Implication
p < α	Reject H0. Statistically significant. But there remains a probability of alpha that this is a Type I error.
p > α	Fail to reject H0. Not statistically significant. A Type II error may have occurred if a real effect exists.
p close to α (e.g., 0.06 when α = 0.05)	Results are suggestive but inconclusive. The sample may be too small to definitively reject or retain H0.
p very small (e.g., 0.001)	Strong evidence against H0. Type I error probability is low, but the result may still lack practical significance.

Changing alpha after seeing the data (post hoc), to achieve a desired p-value threshold, constitutes data dredging and undermines scientific integrity. The significance level must be committed to before analysis.

Which Error Is Worse: Type I or Type II?

Neither type of error is universally worse. The relative severity depends entirely on the real-world consequences of each mistake in the context of the investigation. The following table illustrates how domain-specific considerations shift the priority.

Domain	More Dangerous Error	Reasoning
Drug approval (efficacy)	Type I	Approving an ineffective drug wastes resources and exposes patients to side effects without benefit.
Disease screening	Type II	Missing a positive case (e.g., cancer) allows disease to progress; early detection saves lives.
Safety testing (toxicity)	Type II	Failing to detect a hazardous substance allows harmful products to reach consumers.
Criminal justice	Type I	Convicting an innocent person is widely regarded as the graver injustice.
Quality control	Context-dependent	Rejecting good products is costly; shipping defective products may be dangerous.
Business A/B testing	Context-dependent	Both errors have symmetric financial costs in many commercial scenarios.

A useful heuristic: ask what is the worst that can happen from each type of error. If the cost of wrongly claiming an effect is higher (wasted resources, harmful action, regulatory penalties), minimize alpha. If the cost of missing a real effect is higher (untreated disease, missed safety hazard), minimize beta by maximizing power.

Strategies for Minimizing Type I and Type II Errors

Reducing Type I Error Risk

• Set a lower alpha threshold before the study begins (e.g., 0.01 instead of 0.05).
• Use pre-registration: publicly commit to hypotheses, alpha level, and analysis plan before data collection.
• Apply corrections for multiple comparisons (see below).
• Use replication: a finding that holds across independent samples is unlikely to be a false positive.
• Avoid post hoc hypothesis modification or selective reporting of significant results.

Reducing Type II Error Risk

• Increase the sample size through power analysis to ensure adequate detection capability.
• Target or measure a larger effect size by using more sensitive instruments or more extreme study conditions.
• Increase alpha slightly if the cost of a Type I error is low and the cost of a Type II error is high.
• Reduce measurement error through validated instruments, standardized protocols, and blinded assessment.
• Use within-subjects or paired designs when possible, since they typically increase power compared to between-subjects designs.
• Consider one-tailed tests when only one direction of effect is scientifically meaningful and the decision to use them is pre-specified.

Multiple Testing: When Running Many Tests Inflates Type I Error

Each hypothesis test carries an alpha-level probability of a Type I error. When multiple tests are performed simultaneously, the probability of at least one false positive across the entire set of tests (the family-wise error rate, FWER) increases rapidly. For example, running 20 independent tests at alpha = 0.05 gives an expected FWER of approximately 1 − (0.95)^20 ≈ 64%, meaning a false positive is more likely than not.

Common Correction Methods

Method	What It Controls	Approach	Trade-off
Bonferroni Correction	FWER	Divide alpha by number of tests (α/m)	Very conservative; substantially reduces power in large test families
Holm-Bonferroni	FWER	Step-down procedure; less conservative than Bonferroni	Better power than Bonferroni while still controlling FWER
Benjamini-Hochberg	False Discovery Rate (FDR)	Controls expected proportion of false positives among significant results	Less conservative; preferred when many tests are run (genomics, neuroimaging)
Bonferroni-Sidak	FWER	α* = 1 − (1 − α)^(1/m); slightly less conservative than Bonferroni	Assumes independence of tests

The choice of correction method depends on the number of tests, the independence assumptions, and the relative costs of false positives versus false negatives in the specific application.

Real-World Examples Across Disciplines

Medical and Clinical Research

A clinical trial tests whether a new antidepressant outperforms a placebo. H0: mean depression scores are equal in both groups. A Type I error would lead to approving a drug with no real therapeutic benefit, exposing millions of patients to side effects. A Type II error would prevent a genuinely effective medication from reaching patients. Clinical trials typically use alpha = 0.05 and target 80% or 90% power, with sample sizes determined by power analysis based on the minimum clinically meaningful difference in symptom scores.

Legal System

H0: the defendant is not guilty. A Type I error (convicting an innocent person) is generally considered the graver injustice, which is why criminal justice systems require conviction beyond a reasonable doubt, a stringent standard analogous to a very low alpha. A Type II error (acquitting a guilty person) is the cost of maintaining this high standard.

Manufacturing and Quality Control

A production line tests whether the mean weight of packaged goods meets the specification of 500 g. H0: the process is in control. A Type I error causes the process to be halted unnecessarily, raising production costs. A Type II error allows defective products to continue reaching consumers, potentially triggering regulatory action or product recalls. The relative financial and reputational costs guide the choice of alpha and inspection sample size.

A/B Testing in Technology

A technology company tests whether a new website design increases click-through rates. H0: conversion rates are equal between old and new designs. A Type I error causes the company to deploy a redesign that provides no actual improvement. A Type II error causes the company to reject an effective redesign and forgo revenue gains. When running many simultaneous A/B tests, multiple-comparison corrections are essential to prevent an inflated false positive rate from driving poor product decisions.

Epidemiology and Public Health

A study investigates whether a specific exposure (e.g., a dietary habit) is associated with increased disease incidence. A Type I error would lead public health authorities to issue unwarranted advisories. A Type II error would mean that a genuine risk factor goes undetected, and susceptible populations remain unprotected. The consequences of a Type II error are often considered more damaging in population-level safety contexts.

Errors Due to Bias vs. Random Error

Type I and Type II errors arise from random sampling variation, the unavoidable chance fluctuation in sample statistics. They are distinct from errors caused by bias, which are systematic distortions in measurement or study design.

Error Source	Type	Reducible By
Random sampling variation	Type I or Type II	Increasing sample size
Observer bias	Systematic bias (not Type I/II)	Blinding, standardized protocols
Instrument error (systematic)	Systematic bias (not Type I/II)	Calibration, validated tools
Recall bias	Systematic bias (not Type I/II)	Prospective data collection
Selection bias	Systematic bias (not Type I/II)	Random sampling, representative recruitment

Bias errors are often more difficult to detect and quantify than random errors. They do not average out with larger samples; instead, they systematically push results in one direction, producing misleading effect estimates regardless of sample size.

How Does Hypothesis Quality Affect Error Rates?

Good hypothesis quality reduces the risk of both error types. A poorly framed hypothesis creates ambiguity about what constitutes a rejection of H0, which can lead to post hoc reinterpretation and inflated Type I errors. A vague hypothesis also makes it impossible to specify an effect size for power analysis, preventing effective control of Type II error. The characteristics of a good hypothesis are:

• Simple: one predictor, one outcome variable, enabling a single statistical test.
• Specific: unambiguous definition of study subjects, variables, and measurement approach.
• Stated in advance: committed to in writing before data collection, with a pre-specified alpha level and analysis plan.
• Based on existing evidence: grounded in prior literature or theory, so that the effect size estimate is defensible.

Practical Guidance for Researchers and Analysts

Before the Study: Design Decisions

• Specify the null and alternative hypotheses in writing.
• Choose alpha based on the relative costs of Type I and Type II errors.
• Conduct a power analysis to determine the minimum sample size for the desired power level.
• Estimate effect size from prior literature, pilot data, or the minimum clinically meaningful difference.
• Plan for multiple comparisons if several tests will be run, and select a correction method in advance.
• Register the study design, hypotheses, and analysis plan publicly before data collection.

After the Study: Interpreting Results

• Report the exact p-value, not just whether p < alpha.
• Report effect sizes and confidence intervals alongside p-values.
• Interpret a non-significant result as inconclusive rather than proof of no effect.
• Assess the power of the study post hoc: a non-significant result from an underpowered study is uninformative.
• Do not change the significance level or hypothesis after seeing the data.
• Consider whether the result replicates in independent samples before drawing strong conclusions.

Frequently Asked Questions

Can you have a Type I error and a Type II error at the same time?

No, the two errors are mutually exclusive in any single test. A Type I error occurs only when H0 is true and you reject it; a Type II error occurs only when H0 is false and you fail to reject it. Because H0 is either true or false (not both), only one type of error is possible in a given test, though the researcher does not know which scenario applies.

Does a non-significant p-value prove the null hypothesis is true?

No. Failing to reject the null hypothesis does not confirm it. A non-significant result means only that the observed data are consistent with what would be expected if the null were true; it does not rule out the possibility that a real effect exists. The study may simply have lacked sufficient power to detect it. This is a common misinterpretation, particularly when underpowered studies are used to claim that an effect does not exist.

Why does p-hacking inflate the Type I error rate?

P-hacking refers to practices such as running multiple analyses, collecting data until significance is achieved, or selectively reporting only significant results. Each additional test at alpha = 0.05 contributes an independent 5% chance of a false positive. When many such tests are run and only significant ones are reported, the actual false positive rate across the published findings is far higher than 5%. Pre-registration and correction for multiple comparisons are the primary defenses against this problem.

In machine learning, how do Type I and Type II errors map to model evaluation?

In binary classification, Type I and Type II errors correspond directly to false positives and false negatives in the confusion matrix. A false positive (Type I) is a negative class instance predicted as positive; a false negative (Type II) is a positive class instance predicted as negative. Precision, recall, F1 score, and the ROC curve all reflect different weightings of these two error types. The choice of classification threshold corresponds to setting the alpha level: lowering it reduces false positives at the cost of more false negatives, and raising it does the reverse.

How do Type I and Type II errors apply to A/B testing at scale?

Technology companies running hundreds of simultaneous A/B tests face an acute multiple-testing problem: with 100 tests at alpha = 0.05, approximately five false positives are expected by chance alone. In practice, teams use methods such as the Benjamini-Hochberg procedure (controlling the false discovery rate), sequential testing with alpha spending functions, or Bayesian decision frameworks to manage the balance between shipping true improvements (avoiding Type II errors) and avoiding deployment of ineffective or harmful changes (avoiding Type I errors).

What happens to error rates in small samples?

Small samples produce wide sampling distributions, meaning estimates are imprecise and highly variable. This increases beta (Type II error risk) because the test has low power to distinguish a real effect from noise. However, small samples do not directly inflate alpha, as long as the correct test and significance threshold are applied. The danger is that researchers with small samples may be tempted to raise alpha informally or switch to one-tailed tests after seeing the data, which would inflate Type I error without increasing sample size.

Is a Type II error always less serious than a Type I error in academia?

Historically, academic publishing has been biased toward statistically significant results, creating an incentive structure that implicitly treats Type I errors as desirable (they produce publishable findings) and Type II errors as irrelevant. This incentive structure has contributed to the replication crisis in several scientific fields: many published findings are Type I errors that fail to replicate in larger, better-powered studies. The growing emphasis on effect size reporting, pre-registration, power analysis, and registered reports reflects an effort to reduce this bias and treat Type II errors as equally important.

Can Bayesian methods eliminate the problem of Type I and Type II errors?

Bayesian hypothesis testing replaces fixed error thresholds with probability updates: the posterior probability of the hypothesis given the data. Rather than a binary reject-or-not decision, Bayesian methods quantify the degree of evidence for or against each hypothesis. This framework does not eliminate the risk of incorrect conclusions, but it reframes error control differently, through the choice of prior distributions and the threshold for the Bayes Factor or posterior odds. Bayesian methods are particularly attractive when prior information is available and when the goal is to quantify evidence rather than make a binary decision.